MXCT vs VICI · rev $38.6M vs P/E 9.3, rev $3.85B
MaxCyte Inc (MXCT) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
MXCT currently screens at market cap $124.3M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the MXCT and VICI stock pages for the full models.
Not investment advice.